期刊文献+

鲍氏不动杆菌感染患者死亡影响因素及炎症因子对预后评估的价值 被引量:4

Factors affecting death of patients with Acinetobacter baumannii infection and diagnostic value of inflammatory factors on prognosis
原文传递
导出
摘要 目的探讨血清降钙素原(PCT)、超敏C-反应蛋白(hs-CRP)水平在重症监护病房(ICU)肺部鲍氏不动杆菌感染患者预后的诊断价值,并分析鲍氏不动杆菌感染患者死亡的影响因素。方法选取2015年1月-2019年8月鹰潭市人民医院收治的发生肺部鲍氏不动杆菌感染的ICU患者100例,根据患者28 d后的预后情况分为死亡组(42例)和存活组(58例)。比较两组患者血清PCT、hs-CRP水平和急性生理学和慢性健康状况评分系统Ⅱ(APACHEⅡ)、序贯器官功能衰竭评分(SOFA)评分情况;采用单因素及多因素Logistic回归分析影响ICU肺部鲍氏不动杆菌感染患者预后死亡的影响因素;运用受试者工作特征(ROC)曲线分析PCT、hs-CRP对ICU肺部鲍氏不动杆菌感染患者预后的评估价值。结果 28 d后,ICU肺部鲍氏不动杆菌感染患者的病死率为42.00%。APACHE-Ⅱ评分、SOFA评分、PCT水平、hs-CRP水平是ICU肺部鲍氏不动杆菌感染患者死亡的影响因素(P<0.05)。两项指标联合评估患者预后的特异性、灵敏度、曲线下面积(AUC)分别为88.87%、87.91%、0.885均高于单一指标(P<0.05)。结论血清PCT和hs-CRP水平用于ICU肺部鲍氏不动杆菌感染患者预后具有一定评估价值。 OBJECTIVE To investigate the diagnostic value of serum procalcitonin(PCT) and hypersensitive C-reactive protei(HS-CRP) levels in prognosis of patients with pulmonary Acinetobacter baumaninii infection in intensive care unit(ICU), and to analyze the factors affecting the death of patients with A. baumannii infection. METHODS A total of 100 ICU patients with A. baumannii infection in the lungs who were admitted to Yingtan People′s Hospital from Jan. 2015 to Aug. 2019 were selected, and were divided into death groups(42 cases) and survival group(58 cases) according to the prognosis of the patients 28 days later. The serum PCT and hs-CRP levels, acute physiology and chronic health status scoring system Ⅱ(APACHE Ⅱ), sequential organ failure score(SOFA) scores were compared between the two groups of patients. Univariate and multivariate logistic regression analysis were used to analyze the factors affecting the prognosis and death of ICU patients with A. baumannii infection. Receiver operating characteristics(ROC) curve were used to analyze the prognostic value of PCT and hs-CRP in ICU patients with pulmonary A. baumannii infection. RESULTS After 28 days, the mortality rate of patients with A. baumannii infection in the lungs in the ICU was 42.00%. APACHE-Ⅱ score, SOFA score, PCT level, and hs-CRP level are the influencing factors of death of patients with A. baumannii infection in the lungs of ICU(P<0.05). The specificity, sensitivity, and area under the curve(AUC) of the two indicators combined to assess the prognosis of patients were 88.87%, 87.91%, and 0.885, respectively, significantly higher than a single indicator(P<0.05). CONCLUSION Serum PCT and hs-CRP levels have a certain evaluation value for the prognosis of patients with A. baumannii infection in the ICU.
作者 汪美英 吴卫星 刘春风 陈斌 WANG Mei-ying;WU Wei-xing;LIU Chun-feng;CHEN Bin(Yingtan People's Hospital,Yingtan,Jiangxi 333000,China)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2021年第4期525-529,共5页 Chinese Journal of Nosocomiology
基金 江西省卫生健康委科技计划基金资助项目(20204536)。
关键词 鲍氏不动杆菌 重症监护病房 降钙素原 超敏C-反应蛋白 预后价值 肺部感染 Acinetobacter baumannii Intensive care unit Procalcitonin Hypersensitive C-reactive protei Prognostic value Lung infection
  • 相关文献

参考文献10

二级参考文献64

  • 1Ying Li,Shuping Ge,Yizhi Peng,Xiongwen Chen.Inflammation and cardiac dysfunction during sepsis, muscular dystrophy, and myocarditis[J].Burns & Trauma,2013,1(3):109-121. 被引量:24
  • 2周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:238
  • 3何礼贤.医院获得性肺炎的发病机制及防治[J].中华全科医师杂志,2006,5(10):587-589. 被引量:16
  • 4Kollef MH. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems [ J ]. Respir Care, 2004,49 (12) : 1530-1541.
  • 5Masia M, Gutierrez F, Shum C, et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index [ J ]. Chest,2005,128:2223-2229.
  • 6Boussekey N, Leroy O, Alfandari S, et al. Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia [ J ]. Intensive Care Med ,2006,32(4) :469-472.
  • 7Metersky ML, Ma A, Bratzler DW, et al. Predicting bacteremia in patients with community-acquired pneumonia[ J ]. Am J Respir Crit Care Med, 2004,169 ( 3 ) : 342-347.
  • 8Masterton RG. Antibiotic cycling : more than it might seem [ J ]. J Antimicrob Chemother,2005,55 ( 1 ) : 1-5.
  • 9Confalonieri M, Urbiuo R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study [J]. Am J Respir Crit Care Med ,2005 ,171 (2) :242-248.
  • 10Laterre PF, Garber G, Levy H, et al. Severe community acquired pneumonia as a cause of severe sepsis: data from the PROWESS study[J]. Crit Care Med,2005,33(9) :952-961.

共引文献960

同被引文献40

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部